Patent•
Devices and methods for biochip multiplexing
05 Nov 2001-
TL;DR: In this paper, the authors proposed a method for simultaneous multiple biochip analysis with arrays such as nucleic acid arrays, which allows for high throughput analysis of samples and can be configured to hold multiple cartridges comprising biochips.
Abstract: The invention is directed to devices that allow for simultaneous multiple biochip analysis. In particular, the devices are configured to hold multiple cartridges comprising biochips comprising arrays such as nucleic acid arrays, and allow for high throughput analysis of samples.
Citations
More filters
Patent•
23 Dec 2003
TL;DR: Assay modules as mentioned in this paper are reader apparatuses which may be used to control aspects of module operation and are used to collect and analyze a sample collected on an applicator stick, and can be adapted to receive and analyse a sample.
Abstract: Assay modules, preferably assay cartridges, are described as are reader apparatuses which may be used to control aspects of module operation. The modules preferably comprise a detection chamber with integrated electrodes that may be used for carrying out electrode induced luminescence measurements. Methods are described for immobilizing assay reagents in a controlled fashion on these electrodes and other surfaces. Assay modules and cartridges are also described that have a detection chamber, preferably having integrated electrodes, and other fluidic components which may include sample chambers, waste chambers, conduits, vents, bubble traps, reagent chambers, dry reagent pill zones and the like. In certain preferred embodiments, these modules are adapted to receive and analyze a sample collected on an applicator stick.
506 citations
Patent•
17 May 2001TL;DR: In this paper, a variety of microfluidic devices with configurations including the use of biochannels or microchannels comprising arrays of capture binding ligands to capture target analytes in samples are presented.
Abstract: The present invention is directed to a variety of microfluidic devices with configurations including the use of biochannels or microchannels comprising arrays of capture binding ligands to capture target analytes in samples. The invention provides microfluidic cassettes or devices that can be used to effect a number of manipulations on a sample to ultimately result in target analyte detection or quantification.
442 citations
Patent•
01 Oct 2015
TL;DR: In this article, a system for sample processing is described, which is capable of performing one or more of a sample preparation, sample assay, and detection step using a small volume of sample.
Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
413 citations
Patent•
10 Sep 2004
TL;DR: In this article, an ingestible, implantable or wearable medical device consisting of a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a micro array scanning device capable of obtaining physical parameter data of an interaction between the disease markers with the bioactive agents.
Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device. Specifically, the invention relates to a medical device capable of detecting an analyte in a bodily fluid comprising at least one microneedle capable of obtaining a sample of a bodily fluid, a first microchannel through which the sample flows and is in fluid communication with the at least one microneedle, a second microchannel in fluid communication with the first microchannel, through which a buffer flows, wherein the second channel comprises a microarray with a bioactive agent, a microarray scanning device to detect an interaction between the bioactive agent and the analyte in the bodily fluid; and an interface device.
392 citations
Patent•
29 Dec 2003TL;DR: In this paper, a monolithic elastomer membrane associated with an integrated pneumatic manifold allows the placement and actuation of a variety of fluid control structures, such as structures for pumping, isolating, mixing, routing, merging, splitting, preparing, and storing volumes of fluid.
Abstract: Methods and apparatus for implementing microfluidic analysis devices are provided. A monolithic elastomer membrane associated with an integrated pneumatic manifold allows the placement and actuation of a variety of fluid control structures, such as structures for pumping, isolating, mixing, routing, merging, splitting, preparing, and storing volumes of fluid. The fluid control structures can be used to implement a variety of sample introduction, preparation, processing, and storage techniques.
322 citations
References
More filters
TL;DR: A method for assembling colloidal gold nanoparticles rationally and reversibly into macroscopic aggregates by using the specificity of DNA interactions to direct the interactions between particles of different size and composition is described.
Abstract: COLLOIDAL particles of metals and semiconductors have potentially useful optical, optoelectronic and material properties1–4 that derive from their small (nanoscopic) size. These properties might lead to applications including chemical sensors, spectro-scopic enhancers, quantum dot and nanostructure fabrication, and microimaging methods2–4. A great deal of control can now be exercised over the chemical composition, size and polydis-persity1,2 of colloidal particles, and many methods have been developed for assembling them into useful aggregates and materials. Here we describe a method for assembling colloidal gold nanoparticles rationally and reversibly into macroscopic aggregates. The method involves attaching to the surfaces of two batches of 13-nm gold particles non-complementary DNA oligo-nucleotides capped with thiol groups, which bind to gold. When we add to the solution an oligonucleotide duplex with 'sticky ends' that are complementary to the two grafted sequences, the nanoparticles self-assemble into aggregates. This assembly process can be reversed by thermal denaturation. This strategy should now make it possible to tailor the optical, electronic and structural properties of the colloidal aggregates by using the specificity of DNA interactions to direct the interactions between particles of different size and composition.
6,188 citations
TL;DR: A highly selective, colorimetric polynucleotide detection method based on mercaptoalkyloligonucleotide-modified gold nanoparticle probes is reported, which can detect about 10 femtomoles of an oligonucleotide.
Abstract: A highly selective, colorimetric polynucleotide detection method based on mercaptoalkyloligonucleotide-modified gold nanoparticle probes is reported. Introduction of a single-stranded target oligonucleotide (30 bases) into a solution containing the appropriate probes resulted in the formation of a polymeric network of nanoparticles with a concomitant red-to-pinkish/purple color change. Hybridization was facilitated by freezing and thawing of the solutions, and the denaturation of these hybrid materials showed transition temperatures over a narrow range that allowed differentiation of a variety of imperfect targets. Transfer of the hybridization mixture to a reverse-phase silica plate resulted in a blue color upon drying that could be detected visually. The unoptimized system can detect about 10 femtomoles of an oligonucleotide.
4,334 citations
Patent•
07 Mar 1990
TL;DR: In this paper, a polypeptide array can be synthesized on a substrate by attaching photoremovable groups to the surface of a substrate, exposing selected regions of the substrate to light to activate those regions, attaching an amino acid monomer with a photoregressive group to the activated regions, and repeating the steps of activation and attachment until the desired length and sequences are synthesized.
Abstract: Polypeptide arrays can be synthesized on a substrate by attaching photoremovable groups to the surface of a substrate, exposing selected regions of the substrate to light to activate those regions, attaching an amino acid monomer with a photoremovable group to the activated regions, and repeating the steps of activation and attachment until polypeptides of the desired length and sequences are synthesized. The resulting array can be used to determine which peptides on the array can bind to a receptor.
1,807 citations
TL;DR: In this paper, voltammetric methods were used to probe the interaction (electrostatic or intercalative) of metal complexes, ML 3 3+/2+, with calf thymus DNA.
Abstract: Voltammetric methods were used to probe the interaction (electrostatic or intercalative) of metal complexes, ML 3 3+/2+ , with calf thymus DNA. Binding constants (K n+ ) and binding site sizes (s) were determined from voltammetric data. The exact magnitude for the parameters depends on whether the ML 3 3+/2+ /DNA reaction is assumed to be static (S) or mobile (M) within the characteristic time of a voltammetric experiment
1,567 citations
TL;DR: In this article, a transition-metal complex was used as a molecular light switch for double-helical DNA, which showed no photoluminescence in aqueous solution at ambient temperatures.
Abstract: Considerable research has focused on the development of nonradioactive probes for nucleic acids. Extensive photophysical studies indicate that Ru(phen){sub 3}{sup 2+} bound to double-helical DNA displays an increase in luminescence owing to intercalation; emission from the metal-to-ligand charge transfer (MLCT) excited state decays as a biexponential with one lifetime of 2 {mu}s attributed to the intercalative form and a second lifetime of 0.6 {mu}s (indistinguishable from the free species) assigned to the surface bound form. Here we report the application of a novel transition-metal complex as a true molecular light switch for DNA. This probe is Ru(bpy){sub 2}(dppz){sup 2+} (bpy = 2,2{prime}-bipyridine, dppz = dipyrido(3,2-a:2{prime},3{prime}-c)phenazine), which shows no photoluminescence in aqueous solution at ambient temperatures, but displays intense photoluminescence in the presence of double-helical DNA, to which the complex binds avidly.
1,291 citations